Epidemiology of Venous Thromboembolism in Cardiorespiratory and Infectious Disease

被引:41
作者
Alikhan, Raza [1 ]
Spyropoulos, Alex C. [2 ]
机构
[1] John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England
[2] Lovelace Med Ctr, Clin Thrombosis Ctr, Albuquerque, NM USA
关键词
Chronic obstructive pulmonary disease; Deep vein thrombosis; Epidemiology; Heart failure; Infection; Pulmonary embolism; Thromboprophylaxis; Venous thromboembolism;
D O I
10.1016/j.amjmed.2008.05.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Venous thromboembolic complications-deep vein thrombosis and pulmonary embolism-occur in a significant proportion of hospitalized medical patients. The incidence in acutely ill medical patients is 10%-40%, equivalent to that seen in general surgical patients. Prophylaxis is effective and well tolerated, yet remains under-prescribed in medical wards. Current recommendations for prophylaxis are generalized and do not specifically address many patient groups. Data on the prevalence in patients with chronic obstructive pulmonary disease, heart failure, and infectious diseases are limited. However, studies on large numbers of hospitalized patients with these admission diagnoses have provided important information on incidence, and the efficacy of thromboprophylaxis. This review summarizes current knowledge of the epidemiology of venous thromboembolism in patients with chronic obstructive pulmonary disease, heart failure, and infectious diseases, and highlights the benefits of, and needs for, appropriate prophylaxis in these groups. Increased awareness of the prevalence of thrombosis in the major subgroups of medical inpatients should improve the prescribing of prophylaxis and prevent potentially avoidable and costly complications. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:935 / 942
页数:8
相关论文
共 55 条
[1]   Deep Venous Thrombosis prophylaxis: Are guidelines being followed? [J].
Ahmad, HA ;
Geissler, A ;
MacLellan, DG .
ANZ JOURNAL OF SURGERY, 2002, 72 (05) :331-334
[2]   Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism [J].
Akgun, Metin ;
Meral, Mehmet ;
Onbas, Omer ;
Araz, Omer ;
Koplay, Mustafa ;
Aslan, Sahin ;
Mirici, Arzu .
RESPIRATION, 2006, 73 (04) :428-433
[3]   Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study [J].
Alikhan, R ;
Cohen, AT ;
Combe, S ;
Samama, MM ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Olsson, CG ;
Turpie, AGG .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :963-968
[4]   Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study [J].
Alikhan, R ;
Cohen, AT ;
Combe, S ;
Samama, MM ;
Desjardins, L ;
Eldor, A ;
Janbon, C ;
Leizorovicz, A ;
Olsson, CG ;
Turpie, AGG .
BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (04) :341-346
[5]   Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD [J].
Ambrosetti, M ;
Ageno, W ;
Spanevello, A ;
Salerno, M ;
Pedretti, RFE .
THROMBOSIS RESEARCH, 2003, 112 (04) :203-207
[6]   Thromboprophylaxis rates in US medical centers: success or failure? [J].
Amin, A. ;
Stemkowski, S. ;
Lin, J. ;
Yang, G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) :1610-1616
[7]  
Anderson FA, 2003, BLOOD, V102, p319A
[8]   Missed opportunities for prevention of venous thromboembolism - An evaluation of the use of thromboprophylaxis guidelines [J].
Arnold, DA ;
Kahn, SR ;
Shrier, I .
CHEST, 2001, 120 (06) :1964-1971
[9]   Risk of venous thromboembolism in. patients hospitalized with heart failure [J].
Beemath, Afzal ;
Stein, Paul D. ;
Skaf, Elias ;
Al Sibae, M. Rasm ;
Alesh, Issa .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (06) :793-795
[10]   PREVENTION OF DEEP-VEIN THROMBOSIS IN MEDICAL PATIENTS BY LOW-DOSE HEPARIN [J].
BELCH, JJ ;
LOWE, GDO ;
WARD, AG ;
FORBES, CD ;
PRENTICE, CRM .
SCOTTISH MEDICAL JOURNAL, 1981, 26 (02) :115-117